|
1
|
Circulating epithelial cells in patients with benign colon diseases.
|
Clin Chem
|
2011
|
2.57
|
|
2
|
Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.
|
Mol Cell Biol
|
2006
|
1.37
|
|
3
|
Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
|
Clin Cancer Res
|
2009
|
1.23
|
|
4
|
The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.
|
Oncogene
|
2005
|
1.21
|
|
5
|
KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues.
|
Int J Mol Sci
|
2011
|
1.17
|
|
6
|
RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells.
|
J Mol Diagn
|
2006
|
1.12
|
|
7
|
Capture of viable circulating tumor cells in the liver of colorectal cancer patients.
|
Clin Chem
|
2013
|
1.09
|
|
8
|
Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.
|
Oncogene
|
2002
|
1.09
|
|
9
|
[Clinical proteomics: towards early detection of cancers].
|
Med Sci (Paris)
|
2005
|
1.07
|
|
10
|
Specific activity of class II histone deacetylases in human breast cancer cells.
|
Mol Cancer Res
|
2008
|
1.07
|
|
11
|
Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients.
|
Clin Chem
|
2005
|
1.00
|
|
12
|
Clinical proteomics and mass spectrometry profiling for cancer detection.
|
Expert Rev Proteomics
|
2006
|
1.00
|
|
13
|
1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth.
|
J Neurooncol
|
2012
|
0.99
|
|
14
|
Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?
|
Oncologist
|
2008
|
0.99
|
|
15
|
Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.
|
J Immunol Methods
|
2005
|
0.97
|
|
16
|
HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.
|
PLoS One
|
2012
|
0.95
|
|
17
|
Identifying autoantibody signatures in cancer: a promising challenge.
|
Expert Rev Proteomics
|
2009
|
0.95
|
|
18
|
Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
|
J Clin Oncol
|
2005
|
0.95
|
|
19
|
KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment.
|
Mod Pathol
|
2012
|
0.89
|
|
20
|
Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
|
Int J Cancer
|
2012
|
0.89
|
|
21
|
Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.
|
Clin Chem
|
2013
|
0.89
|
|
22
|
Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.
|
Clin Cancer Res
|
2012
|
0.87
|
|
23
|
Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
|
Cancer Genet Cytogenet
|
2004
|
0.86
|
|
24
|
Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells.
|
Biochem Biophys Res Commun
|
2008
|
0.84
|
|
25
|
Assessment of RNA quality extracted from laser-captured tissues using miniaturized capillary electrophoresis.
|
Lab Invest
|
2003
|
0.83
|
|
26
|
Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection.
|
Anal Biochem
|
2005
|
0.82
|
|
27
|
Comparison of supervised classification methods for protein profiling in cancer diagnosis.
|
Cancer Inform
|
2007
|
0.81
|
|
28
|
Opposite effects of transforming growth factor-beta activation and rho-associated kinase inhibition on human trophoblast migration in a reconstituted placental-endometrial coculture system.
|
Endocrinology
|
2008
|
0.81
|
|
29
|
Steroids and adrenomedullin growth patterns in human ovarian cancer cells: estrogenic-regulation assay.
|
Gynecol Oncol
|
2003
|
0.80
|
|
30
|
Expression of adrenomedullin in human ovaries, ovarian cysts and cancers. Correlation with estrogens receptor status.
|
Eur J Obstet Gynecol Reprod Biol
|
2003
|
0.79
|
|
31
|
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
|
J Thorac Oncol
|
2008
|
0.79
|
|
32
|
Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
|
Int J Biol Markers
|
2011
|
0.79
|
|
33
|
Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids.
|
Proteome Sci
|
2008
|
0.79
|
|
34
|
Clinical relevance of autoantibody detection in lung cancer.
|
J Thorac Oncol
|
2011
|
0.77
|
|
35
|
Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites.
|
J Steroid Biochem Mol Biol
|
2009
|
0.76
|
|
36
|
FKBP family proteins as promising new biomarkers for cancer.
|
Curr Opin Pharmacol
|
2011
|
0.76
|
|
37
|
Hormonal carcinogenesis V. Preface.
|
Adv Exp Med Biol
|
2008
|
0.76
|
|
38
|
[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
|
Bull Cancer
|
2005
|
0.75
|
|
39
|
[Autoantibodies against tumor-related antigens: new tools for early detection of lung cancer].
|
Bull Cancer
|
2011
|
0.75
|
|
40
|
Practical recommendations for hormone replacement therapy in the peri- and postmenopause.
|
Climacteric
|
2004
|
0.75
|
|
41
|
[Genetic alterations of transcription cofactors in solid tumors].
|
Bull Cancer
|
2002
|
0.75
|
|
42
|
[Circulating prognosis markers in melanoma: proteomic profiling and clinical studies].
|
Ann Biol Clin (Paris)
|
2011
|
0.75
|
|
43
|
[Serum autoantibodies profiling and early-stage cancer detection].
|
Med Sci (Paris)
|
2011
|
0.75
|
|
44
|
Expression of estrogen receptors alpha and beta in early steps of human breast carcinogenesis.
|
Adv Exp Med Biol
|
2008
|
0.75
|
|
45
|
[Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].
|
Bull Cancer
|
2004
|
0.75
|